Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Boehringer Ingelheim
Healthtrust
Colorcon
Deloitte
Johnson and Johnson
Accenture
Chinese Patent Office

Generated: June 18, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,625,582

« Back to Dashboard

Summary for Patent: 7,625,582
Title:Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
Abstract:Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:11/738,409
Patent Claims: 1. A method for treating neovascularization in an eye of an individual, comprising: placing a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer in an eye of an individual, thereby treating neovascularization of the eye of the individual.

2. The method of claim 1, wherein the placing comprises placing the bioerodible drug delivery system in the vitreous of the eye.

3. The method of claim 1, wherein the bioerodible drug delivery system comprises dexamethasone.

4. The method of claim 1, wherein the bioerodible polymer comprises a polylactic acid polyglycolic acid (PLGA) copolymer.

5. The method of claim 1, wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least about 5 days.

6. The method of claim 1, wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least about 3 weeks.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Cipla
Deloitte
Healthtrust
Chinese Patent Office
Express Scripts
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.